National registry for chronic pancreatitis in Italy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ITARECIPE project is a multicenter national registry aimed at studying the diagnosis and progression of chronic pancreatitis in Italy. This observational study will collect data on patients' medical histories and outcomes through an electronic data collection form provided by the sponsor. It will include both newly diagnosed patients and those undergoing follow-up visits, with data collected prospectively and retrospectively within a one-year timeframe. The registry will focus on the diverse clinical presentations and treatment approaches for chronic pancreatitis, emphasizing the role of gastroenterologists in patient management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>/= 12 years;
* Diagnosis "definite" or "probable" according to the "M-ANNHEIM" criteria;
* First evidence of diagnosis within 12 months of enrolment.

Exclusion Criteria:

* Age \< 12 years;
* History of known disease with certainty for \> 12 months.

Where it's running

• IRCCS Ospedale San Raffaele
  Milan, Italy Recruiting

Study contacts

• Study coordinator: Gabriele Capurso, PhD
• Email: capurso.gabriele@hsr.it
• Phone: 00390226436548

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CBT-248 safety in healthy adults for chronic pancreatitis support

  This early study tests CBT-248 in healthy adults to see if it is safe, how it behaves in the body, and whether meals affect its levels.

  Recruiting Phase 1 Cibus Therapeutics, Inc. · Melbourne, Victoria · NCT07905053

• Blood protein biomarkers to help diagnose pancreatic cancer in adults

  This study tests whether blood protein biomarkers can help detect pancreatic ductal adenocarcinoma and tell it apart from chronic pancreatitis and mucinous pancreatic lesions, and whether combining markers with CA 19-9 improves accuracy.

  Recruiting Grigore T. Popa University of Medicine and Pharmacy · Iași · NCT07875582

• Relieving a blocked pancreatic duct in chronic pancreatitis

  This pilot study tests whether clearing a blocked pancreatic duct with endoscopy can help people with chronic pancreatitis who have mild symptoms.

  Recruiting Phase 1 Mayo Clinic · Rochester, Minnesota · NCT07810309

• Understanding brain changes in chronic pancreatitis pain

  This study tests whether central nervous system changes and neuropsychological factors help explain persistent pain in adults with chronic pancreatitis.

  Recruiting Asian Institute of Gastroenterology, India · Hyderabad, Telangana · NCT07707609

• EUS-guided pancreaticobiliary procedures with the RIVOS access device

  This study tests how the RIVOS EUS access device performs during interventional procedures for pancreatic and bile duct problems in adults.

  Recruiting Orlando Health, Inc. · Orlando, Florida · NCT07696572

• Odesa Criteria 2026: tests for autoimmune pancreatitis diagnosis

  This study checks if the OC26 scoring system can accurately diagnose autoimmune pancreatitis in adults who may have AIP or related pancreatic diseases.

  Recruiting at 2 sites Military Medical Clinical Center of the Southern Region, Ukraine · Odesa and 1 other locations · NCT07536841

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.